Thank you to all of you who have donated to the Rogue Bloggers for Woodlarks appeal this year. As you might just know, the rogue bloggers (nine confirmed so far) will walk the 33 miles from Horse Hill to Woodlarks on May 25 and we realy want you to sponsor us HERE

Believe it or not AIM PLC directors are meant to be deemed by their Nomad to be “fit and proper” individuals to hold such a post. Don’t all laugh at once. And that brings me to John Zorbas the boss of insolvent Management Resource Solutions (MRS) which is happy to lie to investors.

KEFI Minerals (KEFI) has updated on the first quarter of 2019 – including emphasising Prime Ministerial go-ahead for the Tulu Kapi gold project in Ethiopia and that the Regional Government has begun triggering the consecutive steps of the resettlement programme…

We have a small exposure to Uranium via Berkeley Energia (BKY) but its shares are driven by the Spanish approval process more than the uranium price. But I can't say i'd be averse to a bull market in yellowcake. 

Union Jack Oil (UJO) “is pleased to announce that it has conditionally agreed to sell its 7.5% interest in PEDL143 to UK Oil & Gas” (UKOG)…

Happy Easter weekend to you all. Ahead of more renovation work on the Welsh hovel I ponder a chat with Nigel Wray about why it is always a stockpickers market and about the real crisis facing capitalism, executive greed and abject returns. I have a few more comments about Yourgene (YGEN) where I am even more angry. And ahead of my next training walk I urge you to make an Easter donation to the Woodlarks rogue bloggers HERE

AIM regulation has acknowledged that it has received my formal requests to investigate lies told via RNS and the related party nest of snakes at Management Resource Solutions (MRS). At the centre of it all is 10% shareholder and noted market bad boy Leon Hogan. Now thanks to Winnileaks here is something else for regulators to consider...potential market abuse.

From the FCA's spreadsheet of short positions required to be disclosed to it, the following shows the shorted AIM shares with positions from 2018 and thus far in 2019 (by net short position %, those in bold not on the list at the start of 2019) – and if this position has increased (red), reduced (green) or remained unchanged (black) since last week...

As investors settle down for the Good Friday and Easter bank holiday weekend, Neil Woodford has had a fair degree of coverage to assimilate. Articles in The Times and the FT point to Woodford’s sale of £42 million worth of NewRiver REIT (NRR) to his former junior at Invesco – something which ShareProphets readers have been aware of ten days now (it is good to see the dead wood press keeping up!) Meanwhile Citywire reports that the suspensions of Woodford’s stocks in Guernsey may be resolved this coming week although we are not told which way. And Hargreaves Lansdown appears to be standing by its man, still, as it covers the recent results from WPCT – something covered here some two weeks ago.

Hello, Egg Crackers. As we have a few boring days when shares aren’t moving, there’s time to consider a more important matter. It’s where we will end up after death. We Christians believe that the Easter story shows us where we are going. And yet not even we can be sure.

In today's podcast I look in detail at Managenent Resource Solutions (MRS), Yourgene (YGEN), First Derivatives (FDP) and hapless Neil Woodford and the crashing yield on his Equity Income Fund. How soon will that force Hargeaves Lansdown (HL.) to drop him? And I discuss my plans for weekend training walks as I urge you to become a hero as we surge through 25% of our Rogue Bloggers for Woodlarks target HERE

“Fusion Antibodies plc (AIM: FAB), a pharmaceutical contract research organisation specialising in antibody engineering services, provides a business and unaudited trading update for year ended 31 March 2019, confirming the improvement in second half performance announced on 25 February 2019”. Sounds positive – though despite being down from more than 100p in August and even a start of 2019 more than 50p, the shares nudging up to only 30p?...

A “Directorate Change” announcement follows an “Interim Management Statement” from automotive retailer Pendragon (PDG) – and the shares, at around 23p, are currently more than 10% below levels of earlier this week…

As you will see below, it appears to be some time since AIM-listed POS Inspirit Energy (INSP) updated its AIM Rule 26 webpage. As far as I know, according to AIM Rules, it is supposed to be updated at least every six months but as you can see it was last updated on 26 June 2017. Has London's worst Nomad, Roland Fatty Cornish, really been out to lunch for the last year-and-a bit?...

Provider of wireless solutions for remote tracking, monitoring and protection, Starcom (STAR) “is pleased to announce that the company has conditionally raised £637,500… at a price of 1.25 pence per subscription share”. The market is not pleased – the shares currently more than 20% lower in response…

In the greater scheme of things, given our exposes on the related parties nest of snakes, the blatant RNS lie and the fundamental insolvency of Management Resource Solutions (MRS) this is small beer, but it seems that the Management Team do not give a FF about AIM rules on website disclosure as the screenshot below demonstrates.

A couple of corporate names I own published regulatory news statements this morning. Polymetal (POLY) - which I most recently wrote about here - published its first quarter production numbers. I thought they read well and included a gold equivalent production growth of +27% year-on-year, confirmed key corporate projects such as Pox-2 moves on apace and overall reiterated its full year outlook. As I noted in the above linked piece, all eyes on the upcoming capital markets day later this month and here at/around eight quid a share I rate it as a buy…

First we had a monster rise in the share price of AIM-listed POS Inspirit (INSP). Then yesterday Tom Winnifrith showed us that its factory appeared to have been vacated and re-let to someone else. But there is another small matter…..

Neil Woodford’s funds have just released their latest numbers to the end of March – somewhat earlier than in recent months. The Equity Income Fund continues its path to becoming Patient Capital, is still overdrawn, has been selling more of its income stocks to meet redemptions and the dividend has been chopped. What’s not to like?!

Hello, Share Peckers. A company which has caused me anxiety and loss in the past seems to be on the up. And as I’m not one to hold a grudge, I won't be selling my shares any time soon. In fact, I think the future could be quite rosy from herein - which is nice because I need to claw back a setback which once nudged 80%...